Deferred Tax Assets, Valuation Allowance of Processa Pharmaceuticals, Inc. from 31 Dec 2012 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Processa Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2012 to 31 Dec 2024.
  • Processa Pharmaceuticals, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $19,902,665, a 13% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Processa Pharmaceuticals, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $19,902,665 +$2,263,594 +13% 31 Dec 2024 10-K 20 Mar 2025 2024 FY
Q4 2023 $17,639,071 +$3,096,361 +21% 31 Dec 2023 10-K 20 Mar 2025 2024 FY
Q4 2022 $14,542,710 +$7,454,711 +105% 31 Dec 2022 10-K 29 Mar 2024 2023 FY
Q4 2021 $7,087,999 +$2,948,170 +71% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q4 2020 $4,139,829 +$2,974,703 +255% 31 Dec 2020 10-K 30 Mar 2022 2021 FY
Q4 2019 $1,165,126 +$668,584 +135% 31 Dec 2019 10-K 25 Mar 2021 2020 FY
Q4 2018 $496,542 31 Dec 2018 10-K 06 Mar 2020 2019 FY
Q4 2016 $5,070,442 -$148,182 -3% 31 Dec 2016 10-K 25 Sep 2017 2016 FY
Q4 2015 $4,922,260 -$1,359,848 -38% 31 Dec 2015 10-K 25 Sep 2017 2016 FY
Q4 2014 $3,562,412 -$1,384,473 -64% 31 Dec 2014 10-K 19 Jun 2017 2015 FY
Q4 2013 $2,177,939 -$1,129,740 -108% 31 Dec 2013 10-K 14 Apr 2015 2014 FY
Q4 2012 $1,048,199 31 Dec 2012 10-K 27 Mar 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.